“Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s55. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/1000.